Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

December 2000 (Volume 39, Supplement 2)   [Index by Author] 
 
       SUPPLEMENT
 
Arthritis treatment outcomes: ACCESsing the data
 



To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

SUPPLEMENT:

O. Sangha and M. F. Drummond
Introduction
Rheumatology 2000 39: 1-2; doi:10.1093/rheumatology/39.suppl_2.1 [PDF]  

O. Sangha
Epidemiology of rheumatic diseases
Rheumatology 2000 39: 3-12; doi:10.1093/rheumatology/39.suppl_2.3 [Abstract] [PDF]  

T. M. MacDonald
Epidemiology and pharmacoeconomic implications of non-steroidal anti-inflammatory drug-associated gastrointestinal toxicity
Rheumatology 2000 39: 13-20; doi:10.1093/rheumatology/39.suppl_2.13 [Abstract] [PDF]  

L. Tive
Celecoxib clinical profile
Rheumatology 2000 39: 21-28; doi:10.1093/rheumatology/39.suppl_2.21 [Abstract] [PDF]  

M. F. Drummond
Health economic models: a question of balance—summary of an open discussion on the pharmacoeconomic evaluation of non-steroidal anti-inflammatory drugs
Rheumatology 2000 39: 29-32; doi:10.1093/rheumatology/39.suppl_2.29 [Abstract] [PDF]  

D. Pettitt, J. L. Goldstein, A. McGuire, J. S. Schwartz, T. Burke, and N. Maniadakis
Overview of the Arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib
Rheumatology 2000 39: 33-42; doi:10.1093/rheumatology/39.suppl_2.33 [Abstract] [PDF]  

P. Svarvar and A. Aly
Use of the ACCES model to predict the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis in Norway
Rheumatology 2000 39: 43-50; doi:10.1093/rheumatology/39.suppl_2.43 [Abstract] [PDF]  

U. Haglund and P. Svarvar
The Swedish ACCES model: predicting the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis
Rheumatology 2000 39: 51-56; doi:10.1093/rheumatology/39.suppl_2.51 [Abstract] [PDF]  

Discussion
Rheumatology 2000 39: 57-59; doi:10.1093/rheumatology/39.suppl_2.57 [PDF]  

O. Sangha and M. F. Drummond
Concluding remarks
Rheumatology 2000 39: 60; doi:10.1093/rheumatology/39.suppl_2.60 [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.